Lead Product(s) : Praziquantel
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Charite University, Berlin, Germany | Leiden University Medical Center | Nagasaki University | Umeå University | Merck Group | Ministry of Health, Madagascar
Deal Size : Inapplicable
Deal Type : Inapplicable
Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 03, 2019
Lead Product(s) : Praziquantel
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Charite University, Berlin, Germany | Leiden University Medical Center | Nagasaki University | Umeå University | Merck Group | Ministry of Health, Madagascar
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Praziquantel
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
L-PZQ ODT in Schistosoma Infected Children
Details : Undisclosed
Product Name : L-PZQ
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 19, 2019
Lead Product(s) : Praziquantel
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Praziquantel
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Praziquantel Bioequivalence Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 19, 2018
Lead Product(s) : Praziquantel
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Praziquantel
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Biltricide
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 20, 2016
Lead Product(s) : Praziquantel
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Praziquantel
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Relative Bioavailability Trial of Oral Dispersible Praziquantel Tablets in Healthy Volunteers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 25, 2014
Lead Product(s) : Praziquantel
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Praziquantel
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Hikma Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Schistosoma Haematobium Infections and Praziquantel
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 20, 2012
Lead Product(s) : Praziquantel
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Hikma Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
